Clinical Trial Update: A Study in Patients With Myasthenia Gravis in China

View source ↗

Summary

A clinical trial in China studying Myasthenia Gravis sponsored by AstraZeneca is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Snippet

Sponsor: AstraZeneca | Conditions: Myasthenia Gravis | Status: ACTIVE_NOT_RECRUITING